Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMICIZUMAB for Haemorrhage prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where EMICIZUMAB was used for Haemorrhage prophylaxis.

Most Reported Side Effects for EMICIZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 101 13.8% 7 11
Haemarthrosis 77 10.5% 0 15
No adverse event 77 10.5% 0 0
Haemorrhage 72 9.8% 2 16
Haematoma 30 4.1% 1 7
Fall 23 3.1% 0 6
Headache 23 3.1% 2 3
Arthralgia 22 3.0% 2 1
Drug ineffective 21 2.9% 5 3
Head injury 21 2.9% 0 5
Muscle haemorrhage 19 2.6% 0 7
Pyrexia 18 2.5% 2 9
Drug specific antibody present 17 2.3% 0 0
Injection site reaction 16 2.2% 0 0
Haematuria 13 1.8% 0 5

Other Indications for EMICIZUMAB

Factor viii deficiency (315) Product used for unknown indication (99) Acquired haemophilia (93) Haemophilia a with anti factor viii (70) Haemophilia a without inhibitors (64) Haemophilia (47) Von willebrand's disease (25) Prophylaxis (22)

Other Drugs Used for Haemorrhage prophylaxis

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (343) TRANEXAMIC ACID (207) ANTI-INHIBITOR COAGULANT COMPLEX (56) COAGULATION FACTOR IX RECOMBINANT HUMAN (52) PANTOPRAZOLE (48) EFANESOCTOCOG ALFA (42) EFTRENONACOG ALFA (34) EPINEPHRINE (26) EFMOROCTOCOG ALFA (22) CARBETOCIN (21)

Related Pages

EMICIZUMAB Full Profile All Haemorrhage prophylaxis Drugs EMICIZUMAB Demographics EMICIZUMAB Timeline